Skip to main content

Advertisement

SpringerLink
Log in

Mammalian target of rapamycin (mTOR) as a potential therapeutic target in various diseases

  • Review
  • Published:
Inflammopharmacology Aims and scope Submit manuscript

Abstract

Mammalian target of rapamycin (mTOR) is a serine/threonine protein kinase that belongs to Phosphatidylinositol-3-kinase related kinase superfamily. The signaling pathways of mTOR are integrated through the protein complexes of mTORC1 and mTORC2. mTORC1 controls protein synthesis, cell growth, proliferation, autophagy, cell metabolism, and stress responses, whereas mTORC2 seems to regulate cell survival and polarity. Dysregulation of the mTOR pathway has been implicated in the pathophysiology of a number of disease conditions, including cancer, cardiovascular, neurodegenerative, and various renal diseases. The hyperactivation of the mTOR pathway leads to increase in cell growth and proliferation and also has been documented to stimulate tumor growth. Therefore, investigation of the involvement of mTOR and its downstream pathways in various diseases intensively preoccupied scientific community. The present review is focussed on recent advances in the understanding of the mTOR signaling pathway and its role in health and various diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12

Similar content being viewed by others

References

  • Armengol G, Rojo F, Castellví J, Iglesias C, Cuatrecasas M, Pons B, Baselga J, y Cajal SR (2007) 4E-binding protein 1: a key molecular “funnel factor” in human cancer with clinical implications. Cancer Res 67(16):7551–7555

    Article  CAS  PubMed  Google Scholar 

  • Bärlund M, Forozan F, Kononen J, Bubendorf L, Chen Y, Bittner ML, Torhorst J, Haas P, Bucher C, Sauter G, Kallioniemi OP (2000) Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. J Natl Cancer Inst 92(15):1252–1259

    Article  PubMed  Google Scholar 

  • Bentzinger CF, Romanino K, Cloëtta D, Lin S, Mascarenhas JB, Oliveri F, Xia J, Casanova E, Costa CF, Brink M, Zorzato F (2008) Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab 8(5):411–424

    Article  CAS  PubMed  Google Scholar 

  • Berger Z, Ravikumar B, Menzies FM, Oroz LG, Underwood BR, Pangalos MN, Schmitt I, Wullner U, Evert BO, O’Kane CJ, Rubinsztein DC (2006) Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum Mol Genet 15(3):433–442

    Article  CAS  PubMed  Google Scholar 

  • Bockaert J, Marin P (2015) mTOR in brain physiology and pathologies. Physiol Rev 95(4):1157–1187

    Article  CAS  PubMed  Google Scholar 

  • Brown MS, Goldstein JL (2008) Selective versus total insulin resistance: a pathogenic paradox. Cell Metab 7(2):95–96

    Article  CAS  PubMed  Google Scholar 

  • Brown EJ, Albers MW, Shin TB, Ichikawa K, Keith CT, Lane WS, Schreiber SL (1994) A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369(6483):756–758

    Article  CAS  PubMed  Google Scholar 

  • Caccamo A, Majumder S, Richardson A, Strong R, Oddo S (2010) Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-β, and tau effects on cognitive impairments. J Biol Chem 285(17):13107–13120

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Caccamo A, Maldonado MA, Majumder S, Medina DX, Holbein W, Magrí A, Oddo S (2011) Naturally secreted amyloid-β increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism. J Biol Chem 286(11):8924–8932

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Caccamo A, Magrì A, Medina DX, Wisely EV, López-Aranda MF, Silva AJ, Oddo S (2013) mTOR regulates tau phosphorylation and degradation: implications for Alzheimer’s disease and other tauopathies. Aging Cell 12(3):370–380

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cai Z, Zhao B, Li K, Zhang L, Li C, Quazi SH, Tan Y (2012) Mammalian target of rapamycin: a valid therapeutic target through the autophagy pathway for Alzheimer’s disease? J Neurosci Res 90(6):1105–1118

    Article  CAS  PubMed  Google Scholar 

  • Carnevalli LS, Masuda K, Frigerio F, Le Bacquer O, Um SH, Gandin V, Topisirovic I, Sonenberg N, Thomas G, Kozma SC (2010) S6K1 plays a critical role in early adipocyte differentiation. Dev Cell 18(5):763–774

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cavallucci V, D’Amelio M, Cecconi F (2012) Aβ toxicity in Alzheimer’s disease. Mol Neurobiol 45(2):366–378

    Article  CAS  PubMed  Google Scholar 

  • Chen JK, Chen J, Neilson EG, Harris RC (2005) Role of mammalian target of rapamycin signaling in compensatory renal hypertrophy. J Am Soc Nephrol 16(5):1384–1391

    Article  CAS  PubMed  Google Scholar 

  • Choi KC, Kim SH, Ha JY, Kim ST, Son JH (2010) A novel mTOR activating protein protects dopamine neurons against oxidative stress by repressing autophagy related cell death. J Neurochem 112(2):366–376

    Article  CAS  PubMed  Google Scholar 

  • Clemente CF, Tornatore TF, Theizen TH, Deckmann AC, Pereira TC, Lopes-Cendes I, Souza JRM, Franchini KG (2007) Targeting focal adhesion kinase with small interfering RNA prevents and reverses load-induced cardiac hypertrophy in mice. Circ Res 101(12):1339–1348

    Article  CAS  PubMed  Google Scholar 

  • Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK, Puigserver P (2007) mTOR controls mitochondrial oxidative function through a YY1–PGC-1α transcriptional complex. Nature 450(7170):736–740

    Article  CAS  PubMed  Google Scholar 

  • Das A, Salloum FN, Durrant D, Ockaili R, Kukreja RC (2012) Rapamycin protects against myocardial ischemia–reperfusion injury through JAK2–STAT3 signaling pathway. J Mol Cell Cardiol 53(6):858–869

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • De Benedetti A, Graff JR (2004) eIF-4E expression and its role in malignancies and metastases. Oncogene 23(18):3189–3199

    Article  CAS  PubMed  Google Scholar 

  • Decressac M, Björklund A (2013) mTOR inhibition alleviates L-DOPA-induced dyskinesia in parkinsonian rats. J Parkinson’s Dis 3(1):13–17

    CAS  Google Scholar 

  • Decressac M, Mattsson B, Weikop P, Lundblad M, Jakobsson J, Björklund A (2013) TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity. Proc Natl Acad Sci 110(19):E1817–E1826

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Investig 115(5):1343–1351

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Düvel K, Yecies JL, Menon S, Raman P, Lipovsky AI, Souza AL, Triantafellow E, Ma Q, Gorski R, Cleaver S, Vander Heiden MG (2010) Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell 39(2):171–183

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Efeyan A, Zoncu R, Chang S, Gumper I, Snitkin H, Wolfson RL, Kirak O, Sabatini DD, Sabatini DM (2013) Regulation of mTORC1 by the Rag GTPases is necessary for neonatal autophagy and survival. Nature 493(7434):679–683

    Article  CAS  PubMed  Google Scholar 

  • Elghazi L, Balcazar N, Blandino-Rosano M, Cras-Méneur C, Fatrai S, Gould AP, Chi MM, Moley KH, Bernal-Mizrachi E (2010) Decreased IRS signaling impairs β-cell cycle progression and survival in transgenic mice overexpressing S6K in β-cells. Diabetes 59(10):2390–2399

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Estacio RO, Schrier RW (2000) Diabetic nephropathy: pathogenesis, diagnosis, and prevention of progression. Adv Intern Med 46:359–408

    Google Scholar 

  • Faivre S, Kroemer G, Raymond E (2006) Current development of mTOR inhibitors as anticancer agents. Nat Rev Drug Discov 5(8):671–688

    Article  CAS  PubMed  Google Scholar 

  • Fingar DC, Blenis J (2004) Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 23(18):3151–3171

    Article  CAS  PubMed  Google Scholar 

  • Floto RA, Sarkar S, Perlstein EO, Kampmann B, Schreiber SL, Rubinsztein DC (2007) Small molecule enhancers of rapamycin-induced TOR inhibition promote autophagy, reduce toxicity in Huntington’s disease models and enhance killing of mycobacteria by macrophages. Autophagy 3(6):620–622

    Article  CAS  PubMed  Google Scholar 

  • Fraenkel M, Ketzinel-Gilad M, Ariav Y, Pappo O, Karaca M, Castel J, Berthault MF, Magnan C, Cerasi E, Kaiser N, Leibowitz G (2008) mTOR inhibition by rapamycin prevents β-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes. Diabetes 57(4):945–957

    Article  CAS  PubMed  Google Scholar 

  • Frias MA, Thoreen CC, Jaffe JD, Schroder W, Sculley T, Carr SA, Sabatini DM (2006) mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s. Curr Biol 16(18):1865–1870

    Article  CAS  PubMed  Google Scholar 

  • Fuller TF, Freise CE, Serkova N, Niemann CU, Olson JL, Feng S (2003) Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury. Transplantation 76(11):1594–1599

    Article  CAS  PubMed  Google Scholar 

  • Gan X, Wang J, Wang C, Sommer E, Kozasa T, Srinivasula S, Alessi D, Offermanns S, Simon MI, Wu D (2012) PRR5L degradation promotes mTORC2-mediated PKC-[delta] phosphorylation and cell migration downstream of G [alpha] 12. Nat Cell Biol 14(7):686–696

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • García-Martínez JM, Alessi DR (2008) mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum-and glucocorticoid-induced protein kinase 1 (SGK1). Biochem J 416(3):375–385

    Article  PubMed  CAS  Google Scholar 

  • Grahammer F, Wanner N, Huber TB (2014) mTOR controls kidney epithelia in health and disease. Nephrol Dial Transplant 29(suppl 1):i9–i18

    Article  PubMed  Google Scholar 

  • Gu Y, Lindner J, Kumar A, Yuan W, Magnuson MA (2011) Rictor/mTORC2 is essential for maintaining a balance between β-cell proliferation and cell size. Diabetes 60(3):827–837

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Guertin DA, Stevens DM, Thoreen CC, Burds AA, Kalaany NY, Moffat J, Brown M, Fitzgerald KJ, Sabatini DM (2006) Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCα, but not S6K1. Dev Cell 11(6):859–871

    Article  CAS  PubMed  Google Scholar 

  • Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674

    Article  CAS  PubMed  Google Scholar 

  • Hay N, Sonenberg N (2004) Upstream and downstream of mTOR. Genes Dev 18(16):1926–1945

    Article  CAS  PubMed  Google Scholar 

  • Hostetter TH (1995) Progression of renal disease and renal hypertrophy. Annu Rev Physiol 57(1):263–278

    Article  CAS  PubMed  Google Scholar 

  • Hostetter TH (2003) Hyperfiltration and glomerulosclerosis. WB Saunders. Semin Nephrol 23:194–199

    Article  CAS  PubMed  Google Scholar 

  • Hussain S, Feldman AL, Das C, Ziesmer SC, Ansell SM, Galardy PJ (2013) Ubiquitin hydrolase UCH-L1 destabilizes mTOR complex 1 by antagonizing DDB1-CUL4-mediated ubiquitination of raptor. Mol Cell Biol 33(6):1188–1197

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ikenoue T, Inoki K, Yang Q, Zhou X, Guan KL (2008) Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling. EMBO J 27(14):1919–1931

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Imai Y, Gehrke S, Wang HQ, Takahashi R, Hasegawa K, Oota E, Lu B (2008) Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila. EMBO J 27(18):2432–2443

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Inoki K (2008) Role of TSC–mTOR pathway in diabetic nephropathy. Diabetes Res Clin Pract 82:S59–S62

    Article  CAS  PubMed  Google Scholar 

  • Inoki K, Li Y, Zhu T, Wu J, Guan KL (2002) TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 4(9):648–657

    Article  CAS  PubMed  Google Scholar 

  • Inoki K, Corradetti MN, Guan KL (2005) Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet 37(1):19–24

    Article  CAS  PubMed  Google Scholar 

  • Ito S, Sawada M, Haneda M, Ishida Y, Isobe KI (2006) Amyloid-β peptides induce several chemokine mRNA expressions in the primary microglia and Ra2 cell line via the PI3K/Akt and/or ERK pathway. Neurosci Res 56(3):294–299

    Article  CAS  PubMed  Google Scholar 

  • Ito S, Kimura K, Haneda M, Ishida Y, Sawada M, Isobe KI (2007) Induction of matrix metalloproteinases (MMP3, MMP12 and MMP13) expression in the microglia by amyloid-β stimulation via the PI3K/Akt pathway. Exp Gerontol 42(6):532–537

    Article  CAS  PubMed  Google Scholar 

  • Jacinto E, Loewith R, Schmidt A, Lin S, Ruegg MA, Hall A, Hall MN (2004) Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 6:1122–1128

    Article  CAS  PubMed  Google Scholar 

  • Jacinto E, Facchinetti V, Liu D, Soto N, Wei S, Jung SY, Huang Q, Qin J, Su B (2006) SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127(1):125–137

    Article  CAS  PubMed  Google Scholar 

  • Jiang TF, Zhang YJ, Zhou HY, Wang HM, Tian LP, Liu J, Ding JQ, Chen SD (2013) Curcumin ameliorates the neurodegenerative pathology in A53T α-synuclein cell model of Parkinson’s disease through the downregulation of mTOR/p70S6K signaling and the recovery of macroautophagy. J NeuroImmune Pharmacol 8(1):356–369

    Article  PubMed  Google Scholar 

  • Johnson SC, Rabinovitch PS, Kaeberlein M (2013) mTOR is a key modulator of ageing and age-related disease. Nature 493(7432):338–345

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kantidakis T, Ramsbottom BA, Birch JL, Dowding SN, White RJ (2010) mTOR associates with TFIIIC, is found at tRNA and 5S rRNA genes, and targets their repressor Maf1. Proc Natl Acad Sci 107(26):11823–11828

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Khamzina L, Veilleux A, Bergeron S, Marette A (2005) Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology 146(3):1473–1481

    Article  CAS  PubMed  Google Scholar 

  • Kim JE, Chen J (2004) Regulation of peroxisome proliferator–activated receptor-γ activity by mammalian target of rapamycin and amino acids in adipogenesis. Diabetes 53(11):2748–2756

    Article  CAS  PubMed  Google Scholar 

  • Kim E, Goraksha-Hicks P, Li L, Neufeld TP, Guan KL (2008) Regulation of TORC1 by Rag GTPases in nutrient response. Nat Cell Biol 10(8):935–945

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kumar A, Harris TE, Keller SR, Choi KM, Magnuson MA, Lawrence JC (2008) Muscle-specific deletion of rictor impairs insulin-stimulated glucose transport and enhances Basal glycogen synthase activity. Mol Cell Biol 28(1):61–70

    Article  CAS  PubMed  Google Scholar 

  • Laplante M, Sabatini DM (2009) An emerging role of mTOR in lipid biosynthesis. Curr Biol 19(22):R1046–R1052

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149(2):274–293

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Laplante M, Sabatini DM (2013) Regulation of mTORC1 and its impact on gene expression at a glance. J Cell Sci 126(8):1713–1719

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lavandero S, Foncea R, Pérez V, Sapag-Hagar M (1998) Effect of inhibitors of signal transduction on IGF-1-induced protein synthesis associated with hypertrophy in cultured neonatal rat ventricular myocytes. FEBS Lett 422(2):193–196

    Article  CAS  PubMed  Google Scholar 

  • Le Bacquer O, Petroulakis E, Paglialunga S, Poulin F, Richard D, Cianflone K, Sonenberg N (2007) Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2. J Clin Investig 117(2):387–396

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee CH, Inoki K, Guan KL (2007a) mTOR pathway as a target in tissue hypertrophy. Annu Rev Pharmacol Toxicol 47:443–467

    Article  CAS  PubMed  Google Scholar 

  • Lee MJ, Feliers D, Mariappan MM, Sataranatarajan K, Mahimainathan L, Musi N, Foretz M, Viollet B, Weinberg JM, Choudhury GG, Kasinath BS (2007b) A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy. Am J Physiol Renal Physiol 292(2):F617–F627

    Article  CAS  PubMed  Google Scholar 

  • Li X, Gao T (2014) mTORC2 phosphorylates protein kinase Cζ to regulate its stability and activity. EMBO Rep 15(2):191–198

    CAS  PubMed  Google Scholar 

  • Li L, Zhang X, Le W (2010a) Autophagy dysfunction in Alzheimer’s disease. Neurodegener Dis 7(4):265–271

    PubMed  Google Scholar 

  • Li S, Brown MS, Goldstein JL (2010b) Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proc Natl Acad Sci 107(8):3441–3446

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacoke M, Eng C (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16(1):64–67

    Article  CAS  PubMed  Google Scholar 

  • Lieberthal W, Fuhro R, Andry CC, Rennke H, Abernathy VE, Koh JS, Valeri R, Levine JS (2001) Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells. Am J Physiol Ren Physiol 281(4):F693–F706

    CAS  Google Scholar 

  • Lieberthal W, Fuhro R, Andry C, Patel V, Levine JS (2006) Rapamycin delays but does not prevent recovery from acute renal failure: role of acquired tubular resistance. Transplantation 82(1):17–22

    Article  CAS  PubMed  Google Scholar 

  • Lin X, Parisiadou L, Sgobio C, Liu G, Yu J, Sun L, Shim H, Gu XL, Luo J, Long CX, Ding J (2012) Conditional expression of Parkinson’s disease-related mutant α-synuclein in the midbrain dopaminergic neurons causes progressive neurodegeneration and degradation of transcription factor nuclear receptor related 1. J Neurosci 32(27):9248–9264

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lloberas N, Cruzado JM, Franquesa M, Herrero-Fresneda I, Torras J, Alperovich G, Rama I, Vidal A, Grinyó JM (2006) Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats. J Am Soc Nephrol 17(5):1395–1404

    Article  CAS  PubMed  Google Scholar 

  • Long X, Lin Y, Ortiz-Vega S, Yonezawa K, Avruch J (2005) Rheb binds and regulates the mTOR kinase. Curr Biol 15(8):702–713

    Article  CAS  PubMed  Google Scholar 

  • Lu Z, Xu X, Hu X, Fassett J, Zhu G, Tao Y, Li J, Huang Y, Zhang P, Zhao B, Chen Y (2010) PGC-1α regulates expression of myocardial mitochondrial antioxidants and myocardial oxidative stress after chronic systolic overload. Antioxid Redox Signal 13(7):1011–1022

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ma XM, Blenis J (2009) Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol 10(5):307–318

    Article  PubMed  CAS  Google Scholar 

  • Malagelada C, Jin ZH, Jackson-Lewis V, Przedborski S, Greene LA (2010) Rapamycin Protects against Neuron Death in In Vitro and In Vivo Models of Parkinson’s Disease. J Neurosci 30(3):1166–1175

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mariappan MM, Feliers D, Mummidi S, Choudhury GG, Kasinath BS (2007) High glucose, high insulin, and their combination rapidly induce laminin-β1 synthesis by regulation of mRNA translation in renal epithelial cells. Diabetes 56(2):476–485

    Article  CAS  PubMed  Google Scholar 

  • Mayer C, Zhao J, Yuan X, Grummt I (2004) mTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability. Genes Dev 18(4):423–434

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • McMullen JR, Shioi T, Zhang L, Tarnavski O, Sherwood MC, Kang PM, Izumo S (2003) Phosphoinositide 3-kinase (p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc Natl Acad Sci 100(21):12355–12360

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • McTaggart RA, Gottlieb D, Brooks J, Bacchetti P, Roberts JP, Tomlanovich S, Feng S (2003) Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation. Am J Transplant 3(4):416–423

    Article  CAS  PubMed  Google Scholar 

  • Megyesi J, Andrade L, Vieira JM, Safirstein RL, Price PM (2002) Coordination of the cell cycle is an important determinant of the syndrome of acute renal failure. Am J Physiol Ren Physiol 283(4):F810–F816

    Article  Google Scholar 

  • Menzies FM, Fleming A, Rubinsztein DC (2015) Compromised autophagy and neurodegenerative diseases. Nat Rev Neurosci 16(6):345–357

    Article  CAS  PubMed  Google Scholar 

  • Molitch ME, Defronzo RA, Franz MJ, Keane WF, Mogensen CE, Parving HH, Steffes MW (2004) Nephropathy in diabetes. Diabetes Care 27:S79–S83

    Article  PubMed  Google Scholar 

  • Murata H, Sakaguchi M, Jin Y, Sakaguchi Y, Futami JI, Yamada H, Kataoka K, Huh NH (2011) A New Cytosolic Pathway from a Parkinson Disease-associated Kinase, BRPK/PINK1 ACTIVATION OF AKT VIA MTORC2. J Biol Chem 286(9):7182–7189

    Article  CAS  PubMed  Google Scholar 

  • Nicklin P, Bergman P, Zhang B, Triantafellow E, Wang H, Nyfeler B, Yang H, Hild M, Kung C, Wilson C, Myer VE (2009) Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 136(3):521–534

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nigam SK, Lieberthal W (2000) Acute renal failure. III. The role of growth factors in the process of renal regeneration and repair. Am J Physiol Ren Physiol 279(1):F3–F11

    CAS  Google Scholar 

  • Nobukuni T, Joaquin M, Roccio M, Dann SG, Kim SY, Gulati P, Byfield MP, Backer JM, Natt F, Bos JL, Zwartkruis FJ (2005) Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. Proc Natl Acad Sci USA 102(40):14238–14243

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Oddo S (2012) The role of mTOR signaling in Alzheimer disease. Front Biosci (Scholar edition) 4:941

    Article  Google Scholar 

  • Ozcan U, Ozcan L, Yilmaz E, Düvel K, Sahin M, Manning BD, Hotamisligil GS (2008) Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis. Mol Cell 29(5):541–551

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pastorino JG, Hoek JB (2003) Hexokinase II: the integration of energy metabolism and control of apoptosis. Curr Med Chem 10(16):1535–1551

    Article  CAS  PubMed  Google Scholar 

  • Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R, Landaker EJ (2003) Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci 100(14):8466–8471

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pende M, Kozma SC, Jaquet M, Oorschot V, Burcelin R, Le Marchand-Brustel Y, Klumperman J, Thorens B, Thomas G (2000) Hypoinsulinaemia, glucose intolerance and diminished β-cell size in S6K1-deficient mice. Nature 408(6815):994–997

    Article  CAS  PubMed  Google Scholar 

  • Pérez-Revuelta BI, Hettich MM, Ciociaro A, Rotermund C, Kahle PJ, Krauss S, Di Monte DA (2014) Metformin lowers Ser-129 phosphorylated α-synuclein levels via mTOR-dependent protein phosphatase 2A activation. Cell Death Dis 5(5):e1209

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Peterson RT, Beal PA, Comb MJ, Schreiber SL (2000) FKBP12-rapamycin-associated protein (FRAP) autophosphorylates at serine 2481 under translationally repressive conditions. J Biol Chem 275(10):7416–7423

    Article  CAS  PubMed  Google Scholar 

  • Peterson TR, Laplante M, Thoreen CC, Sancak Y, Kang SA, Kuehl WM, Gray NS, Sabatini DM (2009) DEPTOR is an mTOR inhibitor frequently overeexpressed in multiple myeloma cells and required for their survival. Cell 137(5):873–886

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Peterson TR, Sengupta SS, Harris TE, Carmack A, Kang SA, Balderas E, Guertin DA, Madden KL, Carpenter AE, Finck BN, Sabatini DM (2011) mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell 146(3):408–420

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Philp A, Hamilton DL, Baar K (2011) Signals mediating skeletal muscle remodeling by resistance exercise: PI3-kinase independent activation of mTORC1. J Appl Physiol 110(2):561–568

    Article  CAS  PubMed  Google Scholar 

  • Polak P, Cybulski N, Feige JN, Auwerx J, Rüegg MA, Hall MN (2008) Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. Cell Metab 8(5):399–410

    Article  CAS  PubMed  Google Scholar 

  • Proud CG (2004) Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy. Cardiovasc Res 63(3):403–413

    Article  CAS  PubMed  Google Scholar 

  • Rachdi L, Balcazar N, Osorio-Duque F, Elghazi L, Weiss A, Gould A, Chang-Chen KJ, Gambello MJ, Bernal-Mizrachi E (2008) Disruption of Tsc2 in pancreatic β cells induces β cell mass expansion and improved glucose tolerance in a TORC1-dependent manner. Proc Natl Acad Sci 105(27):9250–9255

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, Oroz LG, Scaravilli F, Easton DF, Duden R, O’Kane CJ, Rubinsztein DC (2004) Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 36(6):585–595

    Article  CAS  PubMed  Google Scholar 

  • Romani-Aumedes J, Canal M, Martin-Flores N, Sun X, Perez-Fernandez V, Wewering S, Fernandez-Santiago R, Ezquerra M, Pont-Sunyer C, Lafuente A, Alberch J (2013) Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson’s disease. Cell Death Dis 5(8):e1364

    Article  CAS  Google Scholar 

  • Sabatini DM, Erdjument-Bromage H, Lui M, Tempst P, Snyder SH (1994) RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78(1):35–43

    Article  CAS  PubMed  Google Scholar 

  • Sadoshima J, Izumo S (1995) Rapamycin selectively inhibits angiotensin II–induced increase in protein synthesis in cardiac myocytes in vitro potential role of 70-kD S6 kinase in angiotensin II–induced cardiac hypertrophy. Circ Res 77(6):1040–1052

    Article  CAS  PubMed  Google Scholar 

  • Sakaguchi M, Isono M, Isshiki K, Sugimoto T, Koya D, Kashiwagi A (2006) Inhibition of mTOR signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice. Biochem Biophys Res Commun 340(1):296–301

    Article  CAS  PubMed  Google Scholar 

  • Sancak Y, Thoreen CC, Peterson TR, Lindquist RA, Kang SA, Spooner E, Carr SA, Sabatini DM (2007) PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell 25(6):903–915

    Article  CAS  PubMed  Google Scholar 

  • Sancak Y, Peterson TR, Shaul YD, Lindquist RA, Thoreen CC, Bar-Peled L, Sabatini DM (2008) The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320(5882):1496–1501

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Santini E, Heiman M, Greengard P, Valjent E, Fisone G (2009) Inhibition of mTOR signaling in Parkinson’s disease prevents L-DOPA–induced dyskinesia. Sci Signal 2(80):ra36

    Article  PubMed  Google Scholar 

  • Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument-Bromage H, Tempst P, Sabatini DM (2004) Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 14(14):1296–1302

    Article  CAS  PubMed  Google Scholar 

  • Sarbassov DD, Guertin DA, Ali SM, Sabatini DM (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307(5712):1098–1101

    Article  CAS  PubMed  Google Scholar 

  • Sataranatarajan K, Mariappan MM, Lee MJ, Feliers D, Choudhury GG, Barnes JL, Kasinath BS (2007) Regulation of elongation phase of mRNA translation in diabetic nephropathy: amelioration by rapamycin. Am J Pathol 171(6):1733–1742

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sato T, Nakashima A, Guo L, Coffman K, Tamanoi F (2010) Single amino-acid changes that confer constitutive activation of mTOR are discovered in human cancer. Oncogene 29(18):2746–2752

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sciarretta S, Zhai P, Shao D, Maejima Y, Robbins J, Volpe M, Condorelli G, Sadoshima J (2012) Rheb is a critical regulator of autophagy during myocardial ischemia pathophysiological implications in obesity and metabolic syndrome. Circulation 125(9):1134–1146

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sciarretta S, Volpe M, Sadoshima J (2014) Mammalian target of rapamycin signaling in cardiac physiology and disease. Circ Res 114(3):549–564

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sciarretta S, Zhai P, Maejima Y, Del Re DP, Nagarajan N, Yee D, Liu T, Magnuson MA, Volpe M, Frati G, Li H (2015) mTORC2 regulates cardiac response to stress by inhibiting MST1. Cell Rep 11(1):125–136

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sekulić A, Hudson CC, Homme JL, Yin P, Otterness DM, Karnitz LM, Abraham RT (2000) A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res 60(13):3504–3513

    PubMed  Google Scholar 

  • Sen S, Kundu BK, Wu HCJ, Hashmi SS, Guthrie P, Locke LW, Roy RJ, Matherne GP, Berr SS, Terwelp M, Scott B (2013) Glucose regulation of load-induced mTOR signaling and ER stress in mammalian heart. J Am Heart Assoc 2(3):e004796

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Sengupta S, Peterson TR, Laplante M, Oh S, Sabatini DM (2010) mTORC1 controls fasting-induced ketogenesis and its modulation by ageing. Nature 468(7327):1100–1104

    Article  CAS  PubMed  Google Scholar 

  • Seth M, Zhang ZS, Mao L, Graham V, Burch J, Stiber J, Tsiokas L, Winn M, Abramowitz J, Rockman HA, Birnbaumer L (2009) TRPC1 channels are critical for hypertrophic signaling in the heart. Circ Res 105(10):1023–1030

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sharma S, Guthrie PH, Chan SS, Haq S, Taegtmeyer H (2007) Glucose phosphorylation is required for insulin-dependent mTOR signalling in the heart. Cardiovasc Res 76(1):71–80

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shaw RJ, Bardeesy N, Manning BD, Lopez L, Kosmatka M, DePinho RA, Cantley LC (2004) The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 6(1):91–99

    Article  CAS  PubMed  Google Scholar 

  • Shigeyama Y, Kobayashi T, Kido Y, Hashimoto N, Asahara SI, Matsuda T, Takeda A, Inoue T, Shibutani Y, Koyanagi M, Uchida T (2008) Biphasic response of pancreatic β-cell mass to ablation of tuberous sclerosis complex 2 in mice. Mol Cell Biol 28(9):2971–2979

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shor B, Wu J, Shakey Q, Toral-Barza L, Shi C, Follettie M, Yu K (2010) Requirement of the mTOR kinase for the regulation of Maf1 phosphorylation and control of RNA polymerase III-dependent transcription in cancer cells. J Biol Chem 285(20):15380–15392

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Simm A, Schlüter KD, Diez C, Piper HM, Hoppe J (1998) Activation of p70 S6 Kinase by β-adrenoceptor Agonists on Adult Cardiomyocytes. J Mol Cell Cardiol 30(10):2059–2067

    Article  CAS  PubMed  Google Scholar 

  • Sparks LM, Xie H, Koza RA, Mynatt R, Hulver MW, Bray GA, Smith SR (2005) A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes 54(7):1926–1933

    Article  CAS  PubMed  Google Scholar 

  • Stemke-Hale K, Gonzalez-Angulo AM, Lluch A, Neve RM, Kuo WL, Davies M, Carey M, Hu Z, Guan Y, Sahin A, Symmans WF (2008) An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer. Cancer Res 68(15):6084–6091

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Subramaniam S, Napolitano F, Mealer RG, Kim S, Errico F, Barrow R, Shahani N, Tyagi R, Snyder SH, Usiello A (2012) Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA-induced dyskinesia. Nat Neurosci 15(2):191–193

    Article  CAS  Google Scholar 

  • Swiech L, Perycz M, Malik A, Jaworski J (2008) Role of mTOR in physiology and pathology of the nervous system. Biochim Et Biophys Acta (BBA) Proteins Proteom 1784(1):116–132

    Article  CAS  Google Scholar 

  • Tamguney T, Stokoe D (2007) New insights into PTEN. J Cell Sci 120(23):4071–4079

    Article  CAS  PubMed  Google Scholar 

  • Tee AR, Manning BD, Roux PP, Cantley LC, Blenis J (2003) Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr Biol 13(15):1259–1268

    Article  CAS  PubMed  Google Scholar 

  • Thoreen CC, Kang SA, Chang JW, Liu Q, Zhang J, Gao Y, Reichling LJ, Sim T, Sabatini DM, Gray NS (2009) An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J Biol Chem 284(12):8023–8032

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tian Y, Bustos V, Flajolet M, Greengard P (2011) A small-molecule enhancer of autophagy decreases levels of Aβ and APP-CTF via Atg5-dependent autophagy pathway. FASEB J 25(6):1934–1942

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tremblay F, Brûlé S, Um SH, Li Y, Masuda K, Roden M, Sun XJ, Krebs M, Polakiewicz RD, Thomas G, Marette A (2007) Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient-and obesity-induced insulin resistance. Proc Natl Acad Sci 104(35):14056–14061

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Um SH, Frigerio F, Watanabe M, Picard F, Joaquin M, Sticker M, Fumagalli S, Allegrini PR, Kozma SC, Auwerx J, Thomas G (2004) Absence of S6K1 protects against age-and diet-induced obesity while enhancing insulin sensitivity. Nature 431(7005):200–205

    Article  CAS  PubMed  Google Scholar 

  • Völkers M, Konstandin MH, Doroudgar S, Toko H, Quijada P, Din S, Joyo A, Ornelas L, Samse K, Thuerauf DJ, Gude N (2013a) Mechanistic target of rapamycin complex 2 protects the heart from ischemic damage. Circulation 128(19):2132–2144

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Völkers M, Toko H, Doroudgar S, Din S, Quijada P, Joyo AY, Ornelas L, Joyo E, Thuerauf DJ, Konstandin MH, Gude N (2013b) Pathological hypertrophy amelioration by PRAS40-mediated inhibition of mTORC1. Proc Natl Acad Sci 110(31):12661–12666

    Article  PubMed  PubMed Central  Google Scholar 

  • Wang L, Gout I, Proud CG (2001) Cross-talk between the ERK and p70 S6 kinase (S6K) signaling pathways MEK-dependent activation of S6K2 in cardiomyocytes. J Biol Chem 276(35):32670–32677

    Article  CAS  PubMed  Google Scholar 

  • Wang X, Hu Z, Hu J, Du J, Mitch WE (2006) Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology 147(9):4160–4168

    Article  CAS  PubMed  Google Scholar 

  • Wang L, Harris TE, Roth RA, Lawrence JC (2007) PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding. J Biol Chem 282(27):20036–20044

    Article  CAS  PubMed  Google Scholar 

  • Wang BT, Ducker GS, Barczak AJ, Barbeau R, Erle DJ, Shokat KM (2011) The mammalian target of rapamycin regulates cholesterol biosynthetic gene expression and exhibits a rapamycin-resistant transcriptional profile. Proc Natl Acad Sci 108(37):15201–15206

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wilson JE (2003) Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. J Exp Biol 206(12):2049–2057

    Article  CAS  PubMed  Google Scholar 

  • Yecies JL, Zhang HH, Menon S, Liu S, Yecies D, Lipovsky AI, Gorgun C, Kwiatkowski DJ, Hotamisligil GS, Lee CH, Manning BD (2011) Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell Metab 14(1):21–32

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yu K, Toral-Barza L, Shi C, Zhang WG, Lucas J, Shor B, Kim J, Verheijen J, Curran K, Malwitz DJ, Cole DC (2009) Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin. Cancer Res 69(15):6232–6240

    Article  CAS  PubMed  Google Scholar 

  • Zhai P, Sciarretta S, Galeotti J, Volpe M, Sadoshima J (2011) Differential roles of GSK-3β during myocardial ischemia and ischemia/reperfusion. Circ Res 109(5):502–511

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang P, Xu X, Hu X, van Deel ED, Zhu G, Chen Y (2007) Inducible Nitric Oxide Synthase Deficiency Protects the Heart From Systolic Overload–Induced Ventricular Hypertrophy and Congestive Heart Failure. Circ Res 100(7):1089–1098

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang HH, Huang J, Düvel K, Boback B, Wu S, Squillace RM, Wu CL, Manning BD (2009) Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway. PLoS One 4(7):e6189

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Zhu XC, Yu JT, Jiang T, Tan L (2013) Autophagy modulation for Alzheimer’s disease therapy. Mol Neurobiol 48(3):702–714

    Article  CAS  PubMed  Google Scholar 

  • Zinzalla V, Stracka D, Oppliger W, Hall MN (2011) Activation of mTORC2 by association with the ribosome. Cell 144(5):757–768

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiovascular Division, Department of Pharmacology, I. S. F. College of Pharmacy, Moga, Punjab, 142001, India

    Avileen Kaur & Saurabh Sharma

Authors
  1. Avileen Kaur
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Saurabh Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Saurabh Sharma.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kaur, A., Sharma, S. Mammalian target of rapamycin (mTOR) as a potential therapeutic target in various diseases. Inflammopharmacol 25, 293–312 (2017). https://doi.org/10.1007/s10787-017-0336-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10787-017-0336-1

Keywords

Search

Navigation